Real-World Outcomes of Patients With Multiple Myeloma Receiving Ide-Cel After Prior BCMA-Targeted Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Cancer Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy
Blood Cancer J 2023 Aug 09;13(1)117, CJ Ferreri, MAT Hildebrandt, H Hashmi, LO Shune, JP McGuirk, DW Sborov, CB Wagner, MH Kocoglu, A Rapoport, S Atrash, PM Voorhees, J Khouri, D Dima, A Afrough, G Kaur, LD Anderson, G Simmons, JA Davis, N Kalariya, LC Peres, Y Lin, M Janakiram, O Nadeem, M Alsina, FL Locke, S Sidana, DK Hansen, KK Patel, OA Castaneda PuglianiniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.